Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Case Reports in Hematology, enter your email address in the box below.

Case Reports in Hematology
Volume 2017 (2017), Article ID 3724017, 9 pages
https://doi.org/10.1155/2017/3724017
Case Report

CD56-Negative Aggressive NK Cell Leukemia Relapsing as Multiple Cranial Nerve Palsies: Case Report and Literature Review

M. Guerreiro,1 F. Príncipe,1 M. J. Teles,2 S. Fonseca,3 A. H. Santos,3 E. Fonseca,4 P. Gomes,1 C. Marques,2 and M. Lima3

1Department of Clinical Hematology, Centro Hospitalar São João, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal
2Department of Clinical Pathology, Centro Hospitalar São João, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal
3Department of Hematology, Laboratory of Cytometry, Hospital de Santo António, Centro Hospitalar do Porto, Rua D. Manuel II, s/n, 4099-001 Porto, Portugal
4Department of Pathology, Centro Hospitalar São João, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal

Correspondence should be addressed to M. Lima; tp.xilc@amil.cmm

Received 21 June 2017; Accepted 6 September 2017; Published 15 October 2017

Academic Editor: Kazunori Nakase

Copyright © 2017 M. Guerreiro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Chan, E. Jan, E. Ralfkiaer et al., “Aggressive NK-cell leukaemia,” in World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, S. Swerdlow, E. Campo, N. Harris et al., Eds., pp. 276–267, International Agency for Research on Cancer (IARC) Press, Lyon, France, 4th edition, 2008. View at Google Scholar
  2. J. Chan, L. Quintanilla-Martinez, J. Ferry et al., “Extranodal NK/T-cell lymphoma, nasal type,” in World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, S. Swerdlow, E. Campo, N. Harris et al., Eds., pp. 285–288, International Agency for Research on Cancer (IARC) Press, Lyon, France, 4th edition, 2008. View at Google Scholar
  3. N. Villamor, L. Chan, and K. Foucar, “Chronic lymphoproliferative disorders of NK cells,” in World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, S. Swerdlow, E. Campo, N. Harris et al., Eds., pp. 274-275, International Agency for Research on Cancer (IARC) Press, Lyon, France, 4th edition, 2008. View at Google Scholar
  4. M. Lima, C. Gonçalves, M. Dos Anjos Teixeira et al., “Aggressive natural-killer cell lymphoma presenting with skin lesions, breast nodule, suprarenal masses and life-threatening pericardial and pleural effusions,” Leukemia and Lymphoma, vol. 42, no. 6, pp. 1385–1391, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Lima, A. Spínola, S. Fonseca et al., “Aggressive mature natural killer cell neoplasms: report on a series of 12 European patients with emphasis on flow cytometry based immunophenotype and DNA content of neoplastic natural killer cells,” Leukemia & Lymphoma, vol. 56, no. 1, pp. 103–112, 2015. View at Publisher · View at Google Scholar
  6. J. K. C. Chan, E. S. Jane, E. Ralfkiaer, and Y. H. Ko, “Aggressive NK-cell leukaemia,” in World Health Organization Classification of Tumours of Haematopoieticand Lymphoid Tissues, S. Swerdlow, E. Campo, N. Harris et al., Eds., pp. 276-277, International Agency for Research on Cancer (IARC) Press, Lyon, France, 4th edition, 2008. View at Google Scholar
  7. J. J. M. Van Dongen, L. Lhermitte, S. Böttcher et al., “EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes,” Leukemia, vol. 26, no. 9, pp. 1908–1975, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. H.-T. Arkenau, G. Chong, D. Cunningham et al., “Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience,” Haematologica, vol. 92, no. 2, pp. 271-272, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Suzuki, J. Suzumiya, S. Nakamura et al., “Aggressive natural killer-cell leukemia revisited: Large granular lymphocyte leukemia of cytotoxic NK cells,” Leukemia, vol. 18, no. 4, pp. 763–770, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. K. Ruskova, R. Thula, and G. T. C. Chan, “Aggressive natural killer-cell leukemia: Report of five cases and review of the literature,” Leukemia and Lymphoma, vol. 45, no. 12, pp. 2427–2438, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. N.-G. Jiang, Y.-M. Jin, Q. Niu, T.-T. Zeng, J. Su, and H.-L. Zhu, “Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood,” Annals of Hematology, vol. 92, no. 1, pp. 89–96, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Gao, A. Behdad, P. Ji, K. L. Wolniak, O. Frankfurt, and Y. Chen, “EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution,” Modern Pathology, vol. 30, no. 8, pp. 1100–1115, 2017. View at Publisher · View at Google Scholar
  13. J.-I. Henter, A. Horne, M. Aric, and M. Aricó, “HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis,” Pediatric Blood Cancer, vol. 48, no. 2, pp. 124–131, 2007. View at Publisher · View at Google Scholar
  14. L. Fardet, L. Galicier, O. Lambotte et al., “Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome,” Arthritis & Rheumatology, vol. 66, no. 9, pp. 2613–2620, 2014. View at Google Scholar
  15. S. Taniguchi, M. Machi, and Y. Ohno, “Epstein-Barr virus-associated CD3- large granular lymphocyte leukemia presenting with polycranial nerve palsies [5],” Blood, vol. 87, no. 11, pp. 4914-4915, 1996. View at Google Scholar · View at Scopus
  16. D. Lackowski, J. L. Koberda, T. G. DeLoughery, and Y. So, “Natural killer cell leukemia as a cause of peripheral neuropathy and meningitis: Case report,” Neurology, vol. 51, no. 2, pp. 640-641, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Lima, “Extranodal NK/T cell lymphoma and aggressive NK cell leukaemia: Evidence for their origin on CD56+bright CD16-/+dim NK cells,” Pathology, vol. 47, no. 6, pp. 503–514, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. B. H. Chang, L. Stork, and G. Fan, “A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type,” Pediatric and Developmental Pathology, vol. 11, no. 1, pp. 50–54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Chang, L. Stork, and G. Fan, “A unique case of Adolescent CD56-negative nasal extranodal NK/T-cell Lymphoma,” Pediatric and Developmental Pathology, vol. 11, no. 4, article 325, 2006. View at Publisher · View at Google Scholar
  20. P. Katsaounis, A. Alexopoulou, S. P. Dourakis et al., “An extranodal NK/T cell lymphoma, nasal type, with specific immunophenotypic and genotypic features,” International Journal of Hematology, vol. 88, no. 2, pp. 202–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. X. Lan, Z. X. Zhen, and W. H. Ming, “CD56-negative extranodal nasal type of natural killerT-cell lymphoma with extranasal skin involvement,” Leukemia and Lymphoma, vol. 50, no. 10, pp. 1715–1717, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. R. Miles, Z. Afify, and H. Yaish, “CD56-negative extranodal nasal type NK/T-cell lymphoma,” Pediatric Blood Cancer, vol. 55, no. 1, pp. 186–189, 2010. View at Google Scholar
  23. R. R. Pine, J. D. Clark, and J. A. Sokol, “CD56 negative extranodal NK/T-cell lymphoma of the orbit mimicking orbital cellulitis,” Orbit, vol. 32, no. 1, pp. 45–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-S. Baek, S.-H. Shin, H.-G. Yi et al., “Cardiac involvement in CD56 negative primary pancreatic extranodal NK/T-cell lymphoma, nasal type, presenting with ventricular tachycardia during the early stages of chemotherapy,” Internal Medicine, vol. 53, no. 20, pp. 2333–2336, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. H. J. Kim, S. H. Kim, and S. H. Oh, “CD56-negative extranodal NK/T-cell lymphoma, nasal type, with extranasal cutaneous involvement,” Annals of Dermatology, vol. 27, no. 5, pp. 618–620, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. Y.-X. Li, H. Wang, X.-L. Feng et al., “Immunophenotypic characteristics and clinical relevance of CD56+ and CD56- extranodal nasal-type natural killer/T-cell lymphoma,” Leukemia and Lymphoma, vol. 52, no. 3, pp. 417–424, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Pongpruttipan, T. Kummalue, A. Bedavanija et al., “Aberrant antigenic expression in extranodal NK/T-cell lymphoma: A multi-parameter study from Thailand,” Diagnostic Pathology, vol. 6, no. 1, article 79, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Wang, Z. Wang, Z.-J. Xia, Y. Lu, H.-Q. Huang, and Y.-J. Zhang, “CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis,” Tumor Biology, vol. 36, no. 10, pp. 7717–7723, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. M. T. Sylvia, S. E. Jacob, and D. Basu, “CD56 Negative Aggressive T Cell Large Granular Lymphocytic Leukemia,” Indian Journal of Hematology Blood Transfusion, vol. 32, pp. 121–124, 2016. View at Google Scholar
  30. J. Sousa, L. Cabezuelo, and S. Almeida, “Aggressive NK/T cell leukemia/lymphoma associated with EBV,” Acta Médica Portuguesa, vol. 24, supplement 3, pp. 649–652, 2011. View at Google Scholar
  31. K. Gaal, N. C. J. Sun, A. M. Hernandez, and D. A. Arber, “Sinonasal NK/T-cell lymphomas in the United States,” American Journal of Surgical Pathology, vol. 24, no. 11, pp. 1511–1517, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. M. L. Gulley and W. Tang, “Using epstein-barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder,” Clinical Microbiology Reviews, vol. 23, no. 2, pp. 350–366, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Liang and D. K. Graham, “Natural killer cell neoplasms,” Cancer, vol. 112, no. 7, pp. 1425–1436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. L. L. Siu, V. Chan, J. K. Chan, K. Wong, R. Liang, and Y. Kwong, “Consistent Patterns of Allelic Loss in Natural Killer Cell Lymphoma,” The American Journal of Pathology, vol. 157, no. 6, pp. 1803–1809, 2000. View at Publisher · View at Google Scholar
  35. H. S. Sun, I.-J. Su, Y.-C. Lin, J.-S. Chen, and S.-Y. Fang, “A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer/T-cell lymphoma,” British Journal of Haematology, vol. 122, no. 4, pp. 590–599, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Huang, A. de Reyniès, L. de Leval et al., “Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type,” Blood, vol. 115, no. 6, pp. 1226–1237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Nakashima, H. Tagawa, R. Suzuki et al., “Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK/T-cell lymphoma, nasal type,” Genes Chromosomes and Cancer, vol. 44, no. 3, pp. 247–255, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Quintanilla-Martinez, M. Kremer, G. Keller et al., “p53 mutations in nasal natural killer/t-cell lymphoma from mexico: Association with large cell morphology and advanced disease,” American Journal of Pathology, vol. 159, no. 6, Article ID 63061, pp. 2095–2105, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Llambi and D. R. Green, “Apoptosis and oncogenesis: give and take in the BCL-2 family,” Current Opinion in Genetics Development, vol. 21, no. 1, pp. 12–20, 2011. View at Publisher · View at Google Scholar
  40. R. Eferl and E. F. Wagner, “AP-1: a double-edged sword in tumorigenesis,” Nature Reviews Cancer, vol. 3, no. 11, pp. 859–868, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. “Cancer Genetics Web,” http://www.cancer-genetics.org.
  42. A. L. Feldman, M. Law, K. L. Grogg et al., “Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization,” American Journal of Clinical Pathology, vol. 130, no. 2, pp. 178–185, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Tse and Y.-L. Kwong, “Treatment algorithms for mature T-cell and natural killer-cell neoplasms,” Future Oncology, vol. 7, no. 9, pp. 1101–1112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Oshimi, “Progress in understanding and managing natural killer-cell malignancies,” British Journal of Haematology, vol. 139, no. 4, pp. 532–544, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Suzuki, “Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia,” International Journal of Hematology, vol. 92, no. 5, pp. 697–701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Saglam, M. Hayran, and A. H. Uner, “Immunohistochemical expression of multidrug resistance proteins in mature T/NK-cell lymphomas,” APMIS, vol. 116, no. 9, pp. 791–800, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. W.-T. Huang, C.-C. Huang, S.-W. Weng, and H.-L. Eng, “Expression of the multidrug resistance protein MRP and the lung-resistance protein LRP in nasal NK/T cell lymphoma: Further exploring the role of P53 and WT1 gene,” Pathology, vol. 41, no. 2, pp. 127–132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Yamaguchi, Y.-L. Kwong, W. S. Kim et al., “Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal Natural Killer (NK)/T-cell lymphoma, nasal type: The NK-cell tumor study group study,” Journal of Clinical Oncology, vol. 29, no. 33, pp. 4410–4416, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. Y.-L. Kwong, W. S. Kim, S. T. Lim et al., “SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group,” Blood, vol. 120, no. 15, pp. 2973–2980, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. “Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma,” ClinicalTrials.gov identifier:NCT00283985, 2017, https://clinicaltrials.gov/ct2/show/NCT00283985.
  51. “Gemcitabine in NK/T Cell Lymphoma,” ClinicalTrials.gov identifier: NCT01660568, 2017, https://clinicaltrials.gov/ct2/show/NCT01660568.
  52. “Treatment of Natural Killer/T Cell Lymphoma-I/II (CTTNKTL-I/II),” ClinicalTrials.gov identifier: NCT01501136, 2017, https://clinicaltrials.gov/ct2/show/NCT01501136.
  53. “Treatment of Natural Killer/T Cell Lymphoma-III/IV (CTTNKTL-III/IV),” ClinicalTrials.gov Identifier: NCT01501149, 2017, https://clinicaltrials.gov/ct2/show/NCT01501149.
  54. R. Suzuki, J. Suzumiya, S. Nakamura et al., “Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms,” Bone Marrow Transplantation, vol. 37, no. 4, pp. 425–431, 2006. View at Publisher · View at Google Scholar
  55. X. Liu, L. Ryland, J. Yang et al., “Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia,” Blood, vol. 116, no. 20, pp. 4192–4201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. S.-B. Ng, V. Selvarajan, G. Huang et al., “Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling,” Journal of Pathology, vol. 223, no. 4, pp. 496–510, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Iqbal, D. D. Weisenburger, A. Chowdhury et al., “Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro,” Leukemia, vol. 25, no. 2, pp. 348–358, 2010. View at Publisher · View at Google Scholar
  58. B. J. Schmiedel, V. Arélin, F. Gruenebach, M. Krusch, S. M. Schmidt, and H. R. Salih, “Azacytidine impairs NK cell reactivity while decitabine augments NK cell responsiveness toward stimulation,” International Journal of Cancer, vol. 128, no. 12, pp. 2911–2922, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Ishitsuka, S. Jimi, V. S. Goldmacher, O. Ab, and K. Tamura, “Targeting CD56 by the maytansinoid immunoconjugate IMGN901 (huN901-DM1): A potential therapeutic modality implication against natural killer/T cell malignancy,” British Journal of Haematology, vol. 141, no. 1, pp. 129–131, 2008. View at Publisher · View at Google Scholar · View at Scopus